Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for exercise capacity in COPD patients with pulmonary hypertension
2010-018763-42Phase 2Completed
- Sponsor
- University of Dundee
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tadalafil in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH), sponsored by University of Dundee. Primary endpoint: Six minute walk test. Started Jun 2010; status: completed.
02
Drugs
tadalafil
03
Conditions
chronic obstructive pulmonary disease (COPD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2010-018763-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018763-42.